绵羊烧伤合并烟雾吸入伤前后血小板与凝血功能变化
该研究为动物实验,15只绵羊经IACUC批准方案麻醉后接受40%全层烧伤合并烟雾吸入伤,在基线、伤后1天及第2、3、4天采血,用血栓弹力图、流式细胞术、聚集法、凝血蛋白水平和游离血红蛋白评估止血功能,Wilcoxon配对检验,显著性设P<0.05。伤后24小时血小板计数下降、活化血小板百分比升高,对ADP的绝对血小板功能反应下降而对胶原无显著差异,按每血小板计ADP反应不变而胶原反应升高,凝血酶原时间和活化部分凝血活酶时间延长,TEG参数较基线显著下降,纤维蛋白原和因子V呈上升趋势,ATIII、因子IX和X下降。6只动物随访至第4天,血小板计数仍低于基线且第2天达最低点,按每血小板计ADP反应不变、胶原反应持续升高,血小板活化水平持续升高,纤维蛋白原和因子V仍显著升高,而TEG参数、凝血酶原时间、因子IX和X恢复至接近基线。作者认为烧伤后存在三阶段凝血病:早期消耗性高凝状态,随后相对低凝伴出血风险增加,再转为相对未知的高凝状态伴血栓性疾病易感性增加。
要点
- 绵羊40%全层烧伤合并烟雾吸入伤后24小时血小板计数下降而活化血小板百分比升高,TEG参数较基线显著下降,呈低凝状态。
- 伤后24小时凝血酶原时间和活化部分凝血活酶时间延长,ATIII、因子IX和X下降,纤维蛋白原和因子V呈上升趋势。
- 伤后24小时对ADP的绝对血小板功能反应下降而对胶原无显著差异,按每血小板计ADP反应不变而胶原反应升高。
- 6只动物随访至第4天,血小板计数仍低于基线且第2天达最低点,纤维蛋白原和因子V仍显著升高,TEG参数、凝血酶原时间、因子IX和X恢复至接近基线。
- 作者认为烧伤凝血病分三阶段:早期消耗性高凝状态、相对低凝伴出血风险增加、再转为相对未知的高凝状态伴血栓性疾病易感性增加。
适用人群与场景
- 15只绵羊,经IACUC批准方案麻醉后接受40%全层烧伤合并烟雾吸入伤,用于研究烧伤病理和止血功能。
- 晚期效应随访6只动物至伤后第4天。
研究设计与关键结果
- 动物实验:15只绵羊接受40%全层烧伤合并烟雾吸入伤,在基线、伤后1天及第2、3、4天采血,用血栓弹力图、流式细胞术、聚集法、凝血蛋白水平和游离血红蛋白评估,Wilcoxon配对检验,显著性设P<0.05。
- 伤后24小时血小板计数下降而活化血小板百分比升高;对ADP的绝对血小板功能反应下降,对胶原无显著差异;按每血小板计ADP反应不变而胶原反应升高。
- 伤后24小时凝血酶原时间和活化部分凝血活酶时间延长,TEG参数较基线显著下降,纤维蛋白原和因子V呈上升趋势,ATIII、因子IX和X下降。
- 6只动物随访至第4天:血小板计数仍低于基线且第2天达最低点;按每血小板计ADP反应不变、胶原反应持续升高;血小板活化水平持续升高;纤维蛋白原和因子V仍显著升高;TEG参数、凝血酶原时间、因子IX和X恢复至接近基线。
证据类型、等级与局限
- 证据类型:动物实验(绵羊烧伤合并烟雾吸入伤模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为烧伤后存在三阶段凝血病:早期消耗性高凝状态,随后相对低凝伴出血风险增加,再转为相对未知的高凝状态伴血栓性疾病易感性增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Smoke inhalation and burn injury remain a major source of morbidity and mortality. There is known dysregulation of hemostasis in burn patients, but either hypercoagulation or hypocoagulation states are reported. Sheep are an established animal model for studying burn pathology and provide robust data on hemostatic function at baseline and after injury.
METHODS: After an IACUC-approved protocol, 15 sheep were anesthetized and subjected to a 40% full thickness burn with smoke inhalation. Blood was sampled at baseline, 1 day postinjury (early effects) and days 2, 3, and 4 (late effects) after injury. Assays at each timepoint assessed: hemostatic function by thromboelastography (TEG), platelet counts and function by flow cytometry and aggregometry, coagulation protein levels, and free hemoglobin. Data were analyzed by the Wilcoxon paired test (nonparametric) with significance set at less than 0.05.
RESULTS: By 24 hours postinjury, platelet counts had dropped, whereas the percent activated platelets increased. Absolute platelet functional response to the agonist adenosine diphosphate (ADP) decreased, whereas response to collagen showed no significant difference. On a per platelet basis, ADP response was unchanged, whereas the collagen response was elevated. Prothrombin time and activated partial thromboplastin time were prolonged. TEG parameters decreased significantly from baseline. Fibrinogen and factor V were trending up; coagulation proteins ATIII, factors IX and X were decreased.Late effects were followed in six animals. At day 4, platelet counts remained depressed compared with baseline with a nadir at day 2; responses to agonist on a per platelet basis remained the same for ADP and stayed elevated for collagen. Platelets continued to have elevated activation levels. Fibrinogen and factor V remained significantly elevated, whereas TEG parameters and prothrombin time, factors IX and X returned to near baseline levels.
CONCLUSION: Coagulation parameters and hemostasis are dysregulated in sheep after smoke inhalation and burn. By 24 hours, sheep were hypocoagulable and subsequently became hypercoagulable by day 4. These results suggest a three-stage coagulopathy in burn injuries with a known early consumptive hypercoagulable state which is followed by a relatively hypocoagulable state with increased bleeding risk and then a return to a relatively unknown hypercoagulability with increased susceptibility to thrombotic disorders.
参考来源
- Prat NJ, Herzig MC, Kreyer S, et al. Platelet and coagulation function before and after burn and smoke inhalation injury in sheep. J Trauma Acute Care Surg. 2017. PMID: 28452873. doi:10.1097/TA.0000000000001472
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。